The China 3D cardiac mapping market has showcased significant growth, with its valuation increasing from $55.55 million in 2019 to a projected $150.59 million by 2027. This report offers a detailed ...

Stereotaxis, Inc. STXS and Shanghai MicroPort EP Medtech Co., Ltd. announced the receipt of regulatory approval from China’s ...